By Katherine Hamilton
Stryker has agreed to acquire medical technology maker Inari Medical, the company said Monday.
The medical technology provider plans to buy all of Inari's common shares for $80 a share, representing a total fully diluted equity value of about $4.9 billion.
Inari, which was founded in 2011, makes mechanical thrombectomy solutions designed to treat peripheral vascular diseases. Stryker said the deal would be complementary to its neurovascular business.
The boards of directors at both companies approved the transaction, which is expected to close during the first quarter.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(MORE TO FOLLOW) Dow Jones Newswires
January 06, 2025 16:24 ET (21:24 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.